| 21/05/24 | 07:00:11 | 21 May 2024 | | Issue of share options |
| 16/05/24 | 07:00:04 | 16 May 2024 | | Presenting at the Sachs 10th Annual Oncology Forum |
| 09/05/24 | 07:00:09 | 9 May 2024 | | Scancell presenting at 21st CIMT Annual Meeting |
| 17/04/24 | 07:00:07 | 17 Apr 2024 | | Presenting at the Annual Immuno-Oncology Summit |
| 16/04/24 | 07:00:12 | 16 Apr 2024 | | Block Listing Six Monthly Return |
| 03/04/24 | 07:00:06 | 3 Apr 2024 | | Employee exercise of share options |
| 02/04/24 | 07:00:09 | 2 Apr 2024 | | Scancell to Present at 2024 AACR Annual Meeting |
| 28/03/24 | 13:21:18 | 28 Mar 2024 | | Scancell Appoints WG as Joint Broker |
| 26/03/24 | 12:22:55 | 26 Mar 2024 | | First iSCIB1+ patient dosed |
| 14/03/24 | 11:17:05 | 14 Mar 2024 | | Appointment of Sath Nirmalananthan to the Board |
| 12/03/24 | 07:00:10 | 12 Mar 2024 | | Scancell Attendance at Upcoming Conferences |
| 04/03/24 | 07:00:06 | 4 Mar 2024 | | Presenting at Next-Gen Immuno-Oncology Conference |
| 20/02/24 | 07:00:07 | 20 Feb 2024 | | Change of Auditor |
| 05/02/24 | 07:00:11 | 5 Feb 2024 | | Directorate Change |
| 30/01/24 | 07:00:06 | 30 Jan 2024 | | Interim Results |
| 26/01/24 | 07:00:07 | 26 Jan 2024 | | Notice of Interim Results and Presentation |
| 17/01/24 | 13:46:09 | 17 Jan 2024 | | Update on SCOPE trial |
| 28/12/23 | 17:36:53 | 28 Dec 2023 | | Holding(s) in Company |
| 27/12/23 | 11:38:01 | 27 Dec 2023 | | Holding(s) in Company |
| 19/12/23 | 07:00:12 | 19 Dec 2023 | | Result of the Open Offer |
| 06/12/23 | 12:41:41 | 6 Dec 2023 | | PDMR Notification |
| 01/12/23 | 07:00:10 | 1 Dec 2023 | | Results of Placing |
| 30/11/23 | 17:03:37 | 30 Nov 2023 | | Proposed Capital Raise to raise approximately £6m |
| 29/11/23 | 14:35:28 | 29 Nov 2023 | | Result of AGM |
| 28/11/23 | 07:00:11 | 28 Nov 2023 | | Update on SCOPE trial |
| 10/11/23 | 08:32:50 | 10 Nov 2023 | | Scancell to present at 20th SMR Congress |
| 01/11/23 | 07:00:10 | 1 Nov 2023 | | Scancell to present at 38th Annual SITC meeting |
| 31/10/23 | 12:00:00 | 31 Oct 2023 | | Notice of AGM |
| 31/10/23 | 07:00:12 | 31 Oct 2023 | | Results for the Year Ended 30 April 2023 |
| 20/10/23 | 07:00:07 | 20 Oct 2023 | | Update on Final Results |
| 18/10/23 | 07:00:08 | 18 Oct 2023 | | Scancell to speak at World Vaccine Congress Europe |
| 17/10/23 | 07:00:11 | 17 Oct 2023 | | Block Listing Six Monthly Return |
| 11/10/23 | 07:00:13 | 11 Oct 2023 | | Change of Date for Final Results |
| 03/10/23 | 07:00:09 | 3 Oct 2023 | | Notice of Final Results and Investor Presentation |
| 19/09/23 | 07:00:05 | 19 Sept 2023 | | Positive data from Phase 2 SCOPE trial with SCIB1 |
| 14/09/23 | 07:00:04 | 14 Sept 2023 | | Scancell to present three posters at ICI |
| 07/09/23 | 07:00:06 | 7 Sept 2023 | | Scancell Appoints Head of Business Development |
| 29/08/23 | 07:00:06 | 29 Aug 2023 | | Scancell Appoints Sath Nirmalananthan as CFO |
| 31/07/23 | 07:00:07 | 31 Jul 2023 | | Modi-1 trial open for expansion in CPI combination |
| 13/07/23 | 09:14:48 | 13 Jul 2023 | | Extension of exercise period for CEO share options |
| 10/07/23 | 07:00:02 | 10 Jul 2023 | | Pipeline strategy and business update |
| 02/06/23 | 07:00:04 | 2 Jun 2023 | | Scancell to Present Modi-1 Data at ASCO |
| 21/04/23 | 07:00:03 | 21 Apr 2023 | | Issue of share options to Non-Executive Directors |
| 18/04/23 | 07:00:02 | 18 Apr 2023 | | ModiFY Phase 1/2 poster presentation at AACR 2023 |
| 17/04/23 | 07:00:05 | 17 Apr 2023 | | Block Listing Application to AIM |
| 13/03/23 | 07:00:07 | 13 Mar 2023 | | Statement re: Silicon Valley Bank (SVB) |
| 21/02/23 | 09:05:45 | 21 Feb 2023 | | Second Price Monitoring Extn |
| 21/02/23 | 09:00:35 | 21 Feb 2023 | | Price Monitoring Extension |
| 21/02/23 | 07:00:03 | 21 Feb 2023 | | Encouraging early efficacy data from ModiFY trial |
| 13/02/23 | 07:00:05 | 13 Feb 2023 | | Positive response in COVIDITY trial |
